Asano K, Shalev A, Phan L, Nielsen K, Clayton J, Valásek L, Donahue T F, Hinnebusch A G
Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development/NIH, Bethesda, MD 20892, USA.
EMBO J. 2001 May 1;20(9):2326-37. doi: 10.1093/emboj/20.9.2326.
eIF5 stimulates the GTPase activity of eIF2 bound to Met-tRNA(i)(Met), and its C-terminal domain (eIF5-CTD) bridges interaction between eIF2 and eIF3/eIF1 in a multifactor complex containing Met-tRNA(i)(Met). The tif5-7A mutation in eIF5-CTD, which destabilizes the multifactor complex in vivo, reduced the binding of Met-tRNA(i)(Met) and mRNA to 40S subunits in vitro. Interestingly, eIF5-CTD bound simultaneously to the eIF4G subunit of the cap-binding complex and the NIP1 subunit of eIF3. These interactions may enhance association of eIF4G with eIF3 to promote mRNA binding to the ribosome. In vivo, tif5-7A eliminated eIF5 as a stable component of the pre-initiation complex and led to accumulation of 48S complexes containing eIF2; thus, conversion of 48S to 80S complexes is the rate-limiting defect in this mutant. We propose that eIF5-CTD stimulates binding of Met-tRNA(i)(Met) and mRNA to 40S subunits through interactions with eIF2, eIF3 and eIF4G; however, its most important function is to anchor eIF5 to other components of the 48S complex in a manner required to couple GTP hydrolysis to AUG recognition during the scanning phase of initiation.
真核起始因子5(eIF5)刺激与甲硫氨酰 - tRNA(i)(Met)结合的eIF2的GTP酶活性,其C末端结构域(eIF5 - CTD)在包含甲硫氨酰 - tRNA(i)(Met)的多因子复合物中桥接eIF2与eIF3 / eIF1之间的相互作用。eIF5 - CTD中的tif5 - 7A突变在体内使多因子复合物不稳定,在体外降低了甲硫氨酰 - tRNA(i)(Met)和mRNA与40S亚基的结合。有趣的是,eIF5 - CTD同时与帽结合复合物的eIF4G亚基和eIF3的NIP1亚基结合。这些相互作用可能增强eIF4G与eIF3的缔合,以促进mRNA与核糖体的结合。在体内,tif5 - 7A消除了eIF5作为起始前复合物的稳定成分,并导致含有eIF2的48S复合物积累;因此,48S向80S复合物的转化是该突变体中的限速缺陷。我们提出,eIF5 - CTD通过与eIF2、eIF3和eIF4G的相互作用刺激甲硫氨酰 - tRNA(i)(Met)和mRNA与40S亚基的结合;然而,其最重要的功能是以起始扫描阶段将GTP水解与AUG识别偶联所需的方式将eIF5锚定到48S复合物的其他成分上。